← Back to Search

Behavioral Intervention

Virtual Reality Therapy for PTSD After COVID-19

Phase < 1
Recruiting
Led By JoAnn Difede, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
A COVID-19 patient or any healthcare worker providing medical care or support for COVID-19 patients
Age ≥18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial will study whether a virtual reality platform can help healthcare workers and COVID-19 patients who develop PTSD resulting from their experiences in the pandemic.

Who is the study for?
This trial is for English-speaking adults over 18 who have PTSD from COVID-19 as patients or healthcare workers. They must be medically stable, able to consent, and not have changed psychotropic meds in the last 60 days. It's not for those with unstable illnesses, current severe risks to themselves or others, a history of motion sickness or seizures, recent psychiatric treatment trials, or psychotic disorders.Check my eligibility
What is being tested?
The study tests Virtual Reality Exposure Therapy on healthcare workers and COVID-19 survivors with PTSD. Participants will undergo ten ninety-minute VR sessions over five weeks to help them process their traumatic experiences related to the pandemic.See study design
What are the potential side effects?
Potential side effects may include discomfort due to virtual reality such as dizziness or nausea (similar to motion sickness), temporary increase in stress levels during exposure therapy sessions, and rare risk of seizures if predisposed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a COVID-19 patient or a healthcare worker caring for COVID-19 patients.
Select...
I am 18 years old or older.
Select...
I have been diagnosed with PTSD.
Select...
I can understand and agree to the study's requirements.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to approximately five weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to approximately five weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability Indicator: Satisfaction
Change in Clinician Administered PTSD Score (CAPS-V)
Feasibility Indicator: Enrollment
+2 more
Secondary outcome measures
Anxiety
Change in Depressive Symptoms measured by the Quick Inventory of Depressive Symptomatology
Change in Score on the Occupational Stress Inventory Revised (OSI-R)
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Virtual Reality Exposure TherapyExperimental Treatment1 Intervention
Virtual Reality Exposure Therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality Exposure Therapy
2006
Completed Phase 3
~610

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,055 Previous Clinical Trials
1,316,274 Total Patients Enrolled
Cornell UniversityOTHER
166 Previous Clinical Trials
14,089,840 Total Patients Enrolled
JoAnn Difede, PhDPrincipal InvestigatorWeill Medical College of Cornell University
5 Previous Clinical Trials
444 Total Patients Enrolled

Media Library

Virtual Reality Exposure Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04887116 — Phase < 1
Post-Traumatic Stress Disorder Research Study Groups: Virtual Reality Exposure Therapy
Post-Traumatic Stress Disorder Clinical Trial 2023: Virtual Reality Exposure Therapy Highlights & Side Effects. Trial Name: NCT04887116 — Phase < 1
Virtual Reality Exposure Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04887116 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What purpose does this investigation seek to fulfill?

"The primary aim of this project, assessed at about 5 weeks post-treatment, is to gauge patient retention. Secondary goals include tracking any changes in the Sheehan Disability Scale (SDS), Quick Inventory of Depressive Symptomatology (QIDS) and Generalized Anxiety Disorder 7-Item Scale scores. For SDS, a score between 0-30 indicates global functional impairment; for QIDS and GAD7, cut offs range from 0-4 representing none to 15-21 as severe anxiety respectively with higher scores indicating greater symptom severity."

Answered by AI

Is this research currently taking on new participants?

"Clinicaltrials.gov states that this research project is no longer in the process of recruiting patients. The trial was posted on January 1st, 2023 and last updated November 15th, 2022 - though 1435 other studies are currently open to participants."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers and Patients Consequent to the COVID-19 Pandemic
2023. "Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers and Patients Consequent to the COVID-19 Pandemic". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04887116.
All > Ptsd New York
~11 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top